Abstract:The C-type lectin receptors (CLRs) Dectin-1 and Dectin-2 are involved in several innate immune responses and are expressed mainly in dendritic cells, monocytes, and macrophages. Dectin-1 activation exacerbates obesity, inflammation, and insulin resistance/type 2 diabetes (T2D). However, the role of Dectin-2 is not clear in T2D. This study aims to evaluate the expression and function of Dectin-2 in peripheral blood mononuclear cells (PBMCs) isolated from diabetic patients and non-diabetic controls. Flow-cytometry and qRT-PCR were performed to evaluate the expression of Dectin-2 in different leukocyte subpopulations isolated from T2D patients (n = 10) and matched non-diabetic controls (n = 11). The functional activity of Dectin-2 was identified in PBMCs. CRP, IL-1β, and TNF-α concentrations were determined by ELISA. siRNA transfection and Western blotting were performed to assess p-Syk and p-NF-kB expression. siRNA transfection was performed to knock down the gene of interest. Our results show that Dectin-2 expression was the highest in monocytes compared with other leukocyte subpopulations. The expression of Dectin-2 was significantly increased in the monocytes of T2D patients compared with non-diabetic controls. Dectin-2 expression positively correlated with markers of glucose homeostasis, including HOMA-IR and HbA1c. The expression of inflammatory markers was elevated in the PBMCs of T2D patients. Interestingly, SOCS3, a negative regulator of inflammation, was expressed significantly lowlier in the PBMCs of T2D patients. Moreover, SOCS3 expression was negatively correlated with Dectin-2 expression level. The further analysis of inflammatory signaling pathways showed a persistent activation of the Dectin-2-Syk-NFkB pathway that was instigated by the diminished expression of SOCS3. Dectin-2 activation failed to induce SOCS3 expression and suppress subsequent inflammatory responses in the PBMCs of diabetic patients. siRNA-mediated knockdown of SOCS3 in PBMCs displayed a similar inflammatory phenotype to diabetic PBMCs when exposed to Dectin-2 ligands. Altogether, our findings suggest that elevated Dectin-2 and its relationship with SOCS3 could be involved in the abnormal immune response observed in T2D patients.

Suppressors of cytokine signaling proteins and diabetes mellitus

Relationship Between Suppressor of Cytokine Signaling -3 and Cell Migration and Invasion

Suppressor of Cytokine Signaling and Insulin Resistance, Leptin Resistance

Role of SOCS-3 in Obesity and Diabetes Mellitus

Regulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3)

SOCS1 Prevents Graft Arteriosclerosis by Preserving Endothelial Cell Function.

Aberrant expression of suppressor of cytokine signaling (SOCS) molecules contributes to the development of allergic diseases

MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes

SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma

The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7

The influence and meaning of SOCS and IFN to the activation of JAK/STAT

Dysregulated expression of the suppressors of cytokine signaling (SOCS) contributes to the development of prostate cancer

[SOCS3: a Potential Therapeutic Target for Many Human Diseases].

Suppressor of Cytokine Signaling 1 Haploinsufficiency

SOCS Proteins Participate in the Regulation of Innate Immune Response Caused by Viruses

The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma

Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis.

SOCS3 Regulates Dectin-2-Induced Inflammation in PBMCs of Diabetic Patients

Suppressor of Cytokine Signaling-1 Has IFN-γ-Independent Actions in T Cell Homeostasis

Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins